|
|||||
|
|
Letter: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance |
|
| Authors: | J.‐F. Jiang J. Sun J. Shi X. Liu |
| Affiliation: | 1. Department of Chemotherapy, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China;2. Department of Medical Affairs, ZiBo Hospital of Integrated Traditional Chinese and Western Medicine, Zibo, China |
| Abstract: | |
| Keywords: | |